نتائج البحث - David Bowen

تنقيح النتائج
  1. 1
    RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years

    RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years حسب David Bowen

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    An association between sub-arachnoid haemorrhage and influenza A infection

    An association between sub-arachnoid haemorrhage and influenza A infection حسب Jones, David Bowen

    منشور في 1979
    احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    A Novel Insecticidal Toxin from <i>Photorhabdus luminescens</i> , Toxin Complex a (Tca), and Its Histopathological Effects on the Midgut of <i>Manduca sexta</i>

    A Novel Insecticidal Toxin from <i>Photorhabdus luminescens</i> , Toxin Complex a (Tca), and Its Histopathological Effects on the Midgut of <i>Manduca sexta</i> حسب Michael B. Blackburn, Elena Golubeva, David Bowen, Richard H. ffrench‐Constant

    منشور في 1998
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Oxidative DNA damage in CD34<sup>+</sup> myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor‐α concentration

    Oxidative DNA damage in CD34<sup>+</sup> myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor‐α concentration حسب Clare Peddie, C. Roland Wolf, Lesley I. McLellan, Andrew Collins, David Bowen

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression

    Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression حسب Catherine Cargo, Nicola J. Rowbotham, Paul Evans, Sharon Barrans, David Bowen, Simon Crouch, Andrew Jack

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors

    Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minim... حسب Panagiotis Kottaridis, Rosemary E. Gale, Stephen E. Langabeer, Marion E. Frew, David Bowen, David C. Linch

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies

    Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies حسب Anna Janowska‐Wieczorek, AR Belch, A Jacobs, David Bowen, Rose Ann Padua, Elisabeth Paietta, E. Richard Stanley

    منشور في 1991
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low‐risk’ myelodysplasia

    A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low‐risk’ myelodysplasia حسب Sally Killick, Ghulam Mufti, Jamie Cavenagh, A Mijović, Janet L. Peacock, E. C. Gordon‐Smith, David Bowen, Judith Marsh

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

    The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee... حسب Maria Nieto, Pierre Démolis, Eliane Béhanzin, Alexandre Moreau, I Hudson, Beatriz Flores, Henry Stemplewski, Tomas Salmonson, Christian Gisselbrecht, David Bowen, Francesco Pignatti

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study

    Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study حسب Norbert Vey, André Bosly, Agnès Guerci, Walter Feremans, Hervé Dombret, F. Dreyfus, David Bowen, Alan K. Burnett, Mike Dennis, Vincent Ribrag, Nicole Casadevall, Laurence Legros, Pierre Fenaux

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

    Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome حسب Ken Mills, Alexander Kohlmann, Paul Williams, Lothar Wieczorek, Wei‐Min Liu, Rachel Li, Wen Wei, David Bowen, H. Loeffler, Jesús María Hernández‐Rivas, Wolf‐Karsten Hofmann, Torsten Haferlach

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

    Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival حسب Alan K. Burnett, Nigel H. Russell, Ann E. Hunter, Donald Milligan, Steven Knapper, Keith Wheatley, John Yin, Mary Frances McMullin, Sahra Ali, David Bowen, Robert K. Hills

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia

    Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia حسب Michael Kirwan, Tom Vulliamy, Anna Marrone, Amanda J. Walne, Richard Beswick, Peter Hillmen, Richard J. Kelly, Andrew Stewart, David Bowen, Stefan Schönland, Annika M. Whittle, Anthony McVerry, Maria Gilleece, Inderjeet Dokal

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

    The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the... حسب Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew, G Harrison, Stephen E. Langabeer, Andrea A. Belton, Helen M. Walker, Keith Wheatley, David Bowen, Alan K. Burnett, Anthony H. Goldstone, David C. Linch

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial

    Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial حسب Simon Stanworth, Sally Killick, Zoe McQuilten, Μαρίνα Καρακάντζα, Robert Weinkove, Heather Smethurst, Laura Pankhurst, Renate Hodge, Valerie Hopkins, Helen Thomas, Alison Deary, Jeannie Callum, Yulia Lin, Erica M. Wood, Rena Buckstein, David Bowen

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts

    The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts حسب Jacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour, Beena Pushkaran, Carrie Fidler, Helen Cattan, Tim Littlewood, Luca Malcovati, Matteo Giovanni Della Porta, Martin Jädersten, Sally Killick, Aristoteles Giagounidis, David Bowen, Eva Hellström‐Lindberg, Mario Cazzola, James S. Wainscoat

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Guidelines for the diagnosis and management of adult myelodysplastic syndromes

    Guidelines for the diagnosis and management of adult myelodysplastic syndromes حسب Sally Killick, CG Carter, Dominic Culligan, Christopher Dalley, Emma Das‐Gupta, Mark W. Drummond, Helen Enright, Gail Jones, Jonathan Kell, Juliet Mills, Ghulam Mufti, Jane E. Parker, Kavita Raj, Alexander Sternberg, Paresh Vyas, David Bowen

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults

    Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults حسب Raphaël Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jorge E. Cortés, Théo de Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Éric Solary, Arjan van de Loosdrecht, Luca Malcovati

    منشور في 2018
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Novel somatic mutations in UBA1 as a cause of VEXAS syndrome

    Novel somatic mutations in UBA1 as a cause of VEXAS syndrome حسب James A. Poulter, Jason C. Collins, Catherine Cargo, Ruth M. de Tute, Paul Evans, Daniela Ospina Cardona, David Bowen, Joanna R. Cunnington, Elaine Baguley, Mark Quinn, Michael Green, Dennis McGonagle, David B. Beck, Achim Werner, Sinisa Savic

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

    Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials حسب Uwe Platzbecker, Pierre Fenaux, Lionel Adès, Aristoteles Giagounidis, Valeria Santini, Arjan A. van de Loosdrecht, David Bowen, T. de Witte, Guillermo Garcia‐Manero, Eva Hellström‐Lindberg, Ulrich Germing, Reinhard Stauder, Luca Malcovati, Mikkael A. Sekeres, David P. Steensma, Silke Gloaguen

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: